关于疫苗相关血栓的重要见解。 - Suppr

Suppr

超能文献

VITT(al) insights into vaccine-related clots.

作者信息

Strich Jeffrey R, Kanthi Yogendra

机构信息

National Institutes of Health Clinical Center.

US Public Health Service Commissioned Corps.

出版信息

Blood. 2021 Dec 2;138(22):2159-2160. doi: 10.1182/blood.2021014195.

DOI:10.1182/blood.2021014195

PMID:34854882

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638213/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1a/8641095/49b559af2cf8/bloodBLD2021014195Cf1.jpg

相似文献

VITT(al) insights into vaccine-related clots.关于疫苗相关血栓的重要见解。

Blood. 2021 Dec 2;138(22):2159-2160. doi: 10.1182/blood.2021014195.

[Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].[肝素诱导的血小板减少症和疫苗诱导的免疫性血栓性血小板减少症：抗血小板因子4抗体的新见解]

Rinsho Ketsueki. 2022;63(9):1233-1241. doi: 10.11406/rinketsu.63.1233.

Potential mechanisms of vaccine-induced thrombosis.疫苗诱导血栓形成的潜在机制。

Eur J Intern Med. 2022 Nov;105:1-7. doi: 10.1016/j.ejim.2022.08.002. Epub 2022 Aug 8.

Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.疑似接种 ChAdOx1 nCoV-19 后出现 VITT 患者的临床评估路径。

Blood Adv. 2022 Jun 14;6(11):3315-3320. doi: 10.1182/bloodadvances.2021006862.

[Novel disease entities due to antiplatelet factor 4 antibodies: HIT, aHIT, and VITT].[抗血小板因子4抗体所致的新型疾病实体：肝素诱导的血小板减少症（HIT）、非肝素诱导的血小板减少症（aHIT）和疫苗诱导的免疫性血小板减少症（VITT）]

Rinsho Ketsueki. 2022;63(5):454-462. doi: 10.11406/rinketsu.63.454.

Understanding vaccine-induced thrombotic thrombocytopenia (VITT).了解疫苗诱导的血栓性血小板减少症（VITT）。

Intern Med J. 2022 May;52(5):717-723. doi: 10.1111/imj.15783. Epub 2022 Apr 21.

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).疫苗诱导的免疫性血栓性血小板减少症（VITT）的治疗。

Semin Hematol. 2022 Apr;59(2):89-96. doi: 10.1053/j.seminhematol.2022.03.002. Epub 2022 Mar 7.

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.疫苗诱导免疫性血栓性血小板减少症所致急性卒中的免疫血栓形成机制研究进展

Front Immunol. 2022 May 10;13:879157. doi: 10.3389/fimmu.2022.879157. eCollection 2022.

Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.新冠病毒疫苗接种后的炎症和血小板活化 - 疫苗诱导免疫性血小板减少症和血栓形成的可能机制。

Front Immunol. 2021 Nov 23;12:779453. doi: 10.3389/fimmu.2021.779453. eCollection 2021.

Longitudinal Aspects of VITT.VITT 的纵向方面。

Semin Hematol. 2022 Apr;59(2):108-114. doi: 10.1053/j.seminhematol.2022.03.001. Epub 2022 Mar 7.

引用本文的文献

Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection.信号转导网络分析表明，福他替尼可能是一种控制 SARS-CoV-2 感染期间血小板过度激活的潜在药物。

Front Immunol. 2023 Dec 21;14:1285345. doi: 10.3389/fimmu.2023.1285345. eCollection 2023.

本文引用的文献

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.腺病毒载体新冠疫苗诱导的免疫性血栓性血小板减少症的相关认识。

Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.

Cooling down VITT with IVIG.用静脉注射免疫球蛋白使疫苗诱导的血栓性血小板减少症降温。

Blood. 2021 Sep 16;138(11):921-922. doi: 10.1182/blood.2021012819.

Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial.福他替尼治疗住院成人 COVID-19：一项随机试验。

Clin Infect Dis. 2022 Aug 24;75(1):e491-e498. doi: 10.1093/cid/ciab732.

Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.腺病毒载体 ChAdOx1 疫苗诱导的血小板减少症中的免疫复合物、固有免疫和 NETosis。

Eur Heart J. 2021 Oct 14;42(39):4064-4072. doi: 10.1093/eurheartj/ehab506.

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。

N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.福他替尼抑制 COVID-19 患者血浆诱导的中性粒细胞胞外陷阱：一种潜在的治疗方法。

J Infect Dis. 2021 Mar 29;223(6):981-984. doi: 10.1093/infdis/jiaa789.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。

Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.COVID-19 住院患者血清中的促血栓形成自身抗体。

Sci Transl Med. 2020 Nov 18;12(570). doi: 10.1126/scitranslmed.abd3876. Epub 2020 Nov 2.

Neutrophil extracellular traps in COVID-19.中性粒细胞胞外陷阱在 COVID-19 中的作用。

JCI Insight. 2020 Jun 4;5(11):138999. doi: 10.1172/jci.insight.138999.

Heparin-induced thrombocytopenia: a historical perspective.肝素诱导的血小板减少症：历史视角

Blood. 2008 Oct 1;112(7):2607-16. doi: 10.1182/blood-2008-02-078014.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验